Cargando…
LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa
Resistance genotypes in pol gene of HIV-1 were obtained by the ViroSeq(®) HIV-1 Genotyping System v2.0 (Celera Diagnostics, Alameda, CA, USA) in 138 of 145 (95%) antiretroviral treatment-experienced adults in virological failure living in Central Africa (Cameroon, Central African Republic, Chad, Gab...
Autores principales: | Mouafo, Linda Chapdeleine Mekue, Péré, Hélène, Ndjoyi-Mbiguino, Angélique, Koyalta, Donato, Longo, Jean De Dieu, Mbopi-Kéou, François-Xavier, Kane, Coumba Toure, Bélec, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353127/ https://www.ncbi.nlm.nih.gov/pubmed/25767633 http://dx.doi.org/10.2174/1874613601509010009 |
Ejemplares similares
-
Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry
por: Koyalta, Donato, et al.
Publicado: (2013) -
Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019) -
Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the WHO recommendations for resource-constrained settings
por: Koyalta, Donato, et al.
Publicado: (2013) -
HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System
por: Johannessen, Asgeir, et al.
Publicado: (2011) -
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2015)